| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,639 | 10,033 | 10,589 | 12,739 | | Cost of Revenue | 1,471 | 1,569 | 1,705 | 2,132 | | | Gross Profit |
-
| 8,464 | 8,884 | 10,607 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,164 | 5,162 | 4,948 | 5,007 | | Non Recurring | 321 | 3,855 | 493 | 907 | | Others | 549 | 6,999 | 1,715 | 2,294 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (7,552) | 1,728 | 2,399 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,134 | (7,552) | 1,728 | 1,967 | | Interest Expense | 240 | 278 | 459 | 836 | | Income Before Tax | 894 | (7,830) | 1,269 | 1,131 | | Income Tax Expense | 201 | (2,104) | 348 | 289 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 693 | (5,726) | 921 | 842 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 693 | (5,726) | 921 | 842 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $693 | ($5,726) | $921 | $842 |
|
0.11% Nasdaq 
0.01%
Income Statement
